Daniel Murphy v. HHS - Influenza, immune thrombocytopenia purpura (ITP) (2023)

Filed 2021-05-06Decided 2023-10-02Vaccine Influenza
compensated$105,280

Case summary [AI summaries can sometimes make mistakes]

On May 6, 2021, Daniel Murphy filed a petition with the National Vaccine Injury Compensation Program. He alleged that on October 9, 2018, he received an influenza vaccine and subsequently suffered from immune thrombocytopenia purpura (ITP), or that the vaccine significantly aggravated a pre-existing injury.

Mr. Murphy also alleged that he experienced residual effects from this condition lasting more than six months.

The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused or aggravated Mr. Murphy's condition.

Despite maintaining their respective positions, both parties agreed to settle the case through a stipulation filed on September 7, 2023. Chief Special Master Brian H.

Corcoran reviewed the stipulation and adopted it as the decision. The stipulation awarded Daniel Murphy a lump sum of $105,280.33, payable by check to the petitioner, as compensation for all damages available under Section 15(a) of the Act.

The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses involved in this case.

Theory of causation

Petitioner Daniel Murphy alleged that on October 9, 2018, he received an influenza vaccine and subsequently suffered from immune thrombocytopenia purpura (ITP), or that the vaccine significantly aggravated a pre-existing injury, with residual effects lasting more than six months. Respondent denied causation. The parties reached a settlement via stipulation, agreeing to an award of $105,280.33. Chief Special Master Brian H. Corcoran adopted the stipulation as the decision. The public text does not specify the theory of causation, medical experts, or the mechanism of injury.

Source PDFs 3 total · 2 downloaded